Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
Versiti Blood Research Institute posted on LinkedIn:
”New research from VBRI investigator Phillip Doerfler uncovers new insights into sickle cell disease protection: uniform expression of fetal hemoglobin matters as much as its quantity.
Doerfler and colleagues from St. Jude Children’s Research Hospital, Christian Medical College Vellore, and University of Minnesota used single-cell RNA sequencing to examine blood cells from patients with two genetic variations that increase fetal hemoglobin, a protein that prevents sickling.
Patients whose cells expressed fetal hemoglobin consistently had no sickle cell symptoms. Patients with dramatic variation (some cells carrying high levels, others with very little) suffered pain crises and acute chest syndrome despite similar average hemoglobin percentages.
The difference is immense. Traditional tests measure what percentage of cells express fetal hemoglobin, but cannot detect how much each cell produces. How can we know whether a patient is protected?
The discovery offers crucial guidance for gene therapy approaches that reactivate fetal hemoglobin. Consistency of expression across the cell population may predict clinical benefit better than average levels alone.
Read the article in Blood Journals Portfolio’s Blood.
Advances here.”
Title: Single-cell transcriptomics reveals heterocellular g-globin gene expression in Agdb-thalassemia
Authors: Phillip A Doerfler, Yichao Li, Yu Yao, Ruopeng Feng, Thiyagaraj Mayuranathan, Jingjing Zhang, Emilia Kooienga, David Cullins, Rohith Jesudas, Dillon C Williams, Jane S Hankins, Yong Cheng, David K Wood, Mitchell J. Weiss
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy